Detalhe da pesquisa
1.
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.
J Viral Hepat
; 28(9): 1256-1264, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003556
2.
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
Antimicrob Agents Chemother
; 56(3): 1364-75, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203606